FMA
RPTP

FNY Managed Accounts’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

FNY Managed Accounts’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-12,423
Closed -$111K – 430
2016
Q3 		$111K Buy
+12,423
New +$88.3K 0.09% 131

FNY Managed Accounts's RPTP Position: Q4 2016 in Review

FNY Managed Accounts sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 12,423 shares — an estimated $111K sold.

FNY Managed Accounts first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $111K in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • FNY Managed Accounts reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • FNY Managed Accounts sold 12,423 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $111K.
  • FNY Managed Accounts first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2016 and held it in 1 quarter.
  • FNY Managed Accounts's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $111K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on FNY Managed Accounts's 13F filing for Q4 2016, filed 8 Feb 2017.